BCIQ Profiles

Company Profile ReportTarget Profile Report
DIST_0805_j.cell.2021.06.031

CaMKII gene therapy to preserve retinal ganglion cells

Aug 27, 2021 | 9:22 PM GMT

DISEASE CATEGORY: Ophthalmic; neurology

INDICATION: Glaucoma

CaMK2 gene therapy

Read the full 184 word article

How to gain access

Continue reading with a
two-week free trial.